Clinical Trial Uses Adult Stem Cells to Treat Diabetes
A new clinical trial at the University of Wisconsin at Madison is using mesenchymal stem cells in the treatment of patients with Type 1 diabetes.
August 10, 2009
A new clinical trial at the University of Wisconsin at Madison is using mesenchymal stem cells in the treatment of patients with Type 1 diabetes.
Once again, the successful use of autologous adult stem cells for the treatment of animals is in the news.
Once again, autologous adult stem cell therapy is successfully used to treat man’s best friend.
Biotech giant Novartis agrees to pay $4 million to Opexa Therapeutics for its proprietary adult stem cell technology.
Scientists apply principles of proteomics to embryonic stem cells in order to learn more about cellular differentiation.
The pharmaceutical company Athersys Inc. has announced that it is seeking commercial partners for the development and testing of its stem cell and drug therapies.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.